S. M. Wolff - Concepedia

Author

S. M. Wolff

Also Known As

S M Wolff, S WOLFF, S Wolff, S. M. WOLFF, S. M. Wolff, S. Wolff, S.M. Wolff, STEWART M. WOLFF, Sheldon M. Wolff, Sheldon Wolff

Publications

10.2K

Citations

H-Index

153

Concepts

All Affiliations

Tufts Medical Center National Institute of Allergy and Infectious Diseases National Institutes of Health Tufts University University of California, San Francisco

About

S. M. Wolff is an author at Tufts Medical Center specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	40	7.5K
2	Health Sciences	7	7	385
3	Education	2	2	99
4	Natural Sciences	2	2	59
5	Engineering	1	1	122

S. M. Wolff

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Detection of Circulating Tumor Necrosis Factor after Endotoxin Administration H. R. Michie, Kirk R. Manogue, David R. Spriggs, New England Journal of Medicine ImmunologyPathologyInflammationBiomarker (Medicine)Translational Medicine	1988	1.7K
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. C A Dinarello, Joseph G. Cannon, S. M. Wolff, The Journal of Experimental Medicine ImmunologyImmune RegulationPathologyCell DeathImmunologic Mechanism	1986	1.5K
Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Philip E. Auron, Andrew C. Webb, Lanny J. Rosenwasser, Proceedings of the National Academy of Sciences InflammationCytokineImmunogeneticsMolecular ImmunologyActive Il-1	1984	1K
Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever Joseph G. Cannon, Ronald G. Tompkins, Jeffrey A. Gelfand, The Journal of Infectious Diseases	1990	762
Sleep-promoting effects of endogenous pyrogen (interleukin-1) James M. Krueger, James Walter, C A Dinarello, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology Sleep DisordersSocial SciencesInflammationPhysiological ResearchSomnogenic Activity	1984	457
A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. Amy Chernoff, Eric V. Granowitz, Leland Shapiro, The Journal of Immunology	1995	420
Production of interleukin-1-receptor antagonist during experimental endotoxaemia Eric V. Granowitz, Debra D. Poutsiaka, Joseph G. Cannon, The Lancet InflammationCytokineImmunologyHematologyBlood Cell	1991	313
Human leukocytic pyrogen: purification and development of a radioimmunoassay. Charles A. Dinarello, Lois Renfer, S. M. Wolff Proceedings of the National Academy of Sciences Clinical ImmunologyImmunocytochemical TechniqueMedicinePathogenesisImmunology	1977	270
A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection. J W van der Meer, Michael Barza, S. M. Wolff, Proceedings of the National Academy of Sciences ImmunotoxicologyLow DoseLethal Gram-negative InfectionImmune RegulationImmunology	1988	240
Nonspecificity of the Limulus Amebocyte Lysate Test: Positive Reactions with Polynucleotides and Proteins Ronald J. Elin, S. M. Wolff The Journal of Infectious Diseases Clinical ImmunologyImmunohematologyLaboratory ImmunologyImmunodeficienciesMaryland Search	1973	217

Page 1